Prevalence of metabolic syndrome and its components in Chinese women with premature ovarian insufficiency

Gynecol Endocrinol. 2023 Dec;39(1):2254847. doi: 10.1080/09513590.2023.2254847.

Abstract

Objectives: To assess the prevalence of metabolic syndrome (MetS) and its components in Chinese women with premature ovarian insufficiency (POI) and to explore the metabolic profile of Chinese women with POI.

Methods: 118 POI women aged 20-38 years and 151 age-and-BMI-matched control women were recruited. Measurements included body height, weight, waist circumference (WC), hip circumference (HC), blood pressure, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG) and fasting insulin (FINS). Prevalence and components of MetS and metabolic indices were compared between the two groups.

Results: The prevalence of MetS in POI women and age-and-BMI-matched control women was 16.9% and 11.3%, respectively, which was not significantly different (p > .05). The prevalence of hypertriglyceridemia and high fasting glucose was significantly higher in POI than control (17.8% vs. 9.3%, p = .039; 16.9% vs. 6.6%, p = .008), without significant differences in the prevalence of other components of MetS (p > .05). The levels of TG, FINS, and HOMA-IR in POI were significantly higher than in control (p < .05) but without significant differences in WC, WHR, SBP, DBP, TC, HDL-C, LDL-C, and FPG (p > .05). HOMA-IR was positively correlated with WC, DBP, TG, and FPG and negatively correlated with HDL-C in both POI women and control (p < .05).

Conclusions: POI women presented with more unfavorable cardiovascular risk factors (higher prevalence of hypertriglyceridemia and high fasting glucose; higher TG, FINS, and HOMA-IR). So, women diagnosed with POI should always be covered with special care of metabolic profile.

Keywords: Premature ovarian insufficiency (POI); insulin resistance; metabolic profile; metabolic syndrome (MetS).

MeSH terms

  • Adult
  • Cholesterol, HDL
  • Cholesterol, LDL
  • East Asian People
  • Female
  • Glucose
  • Humans
  • Hypertriglyceridemia*
  • Menopause, Premature*
  • Metabolic Syndrome* / epidemiology
  • Prevalence
  • Primary Ovarian Insufficiency* / epidemiology
  • Young Adult

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Glucose